Use of Mycophenolate Mofetil Suspension as Part of Induction Therapy After Living-Donor Liver Transplant.

CONCLUSIONS: Mycophenolate mofetil suspension is useful as part of immunosuppressive induction therapy after living-donor liver transplant because its concentration increases greater than that of mycophenolate mofetil capsules and because of the low risk of rejection and adverse events.
PMID: 32490763 [PubMed - as supplied by publisher]

Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation - June 1, 2020 Category: Transplant Surgery Authors: Harada N, Yoshizumi T, Yoshiya S, Takeishi K, Toshima T, Itoh S, Ikegami T, Fukuda M, Masuda S, Mori M Tags: Exp Clin Transplant Source Type: research